The urogenital tract undergoes profound physiological transformations as ovarian function declines. Both the lower urinary tract and the genital organs share a common embryological origin from the urogenital sinus and pelvic floor mesoderm, making them exceptionally sensitive to fluctuating and diminishing sex steroid hormones. Midwives in Nigerian clinical practice frequently encounter women navigating these midlife transitions who report subtle vaginal dryness, pelvic heaviness, or sudden urinary urgency. Understanding these anatomical shifts requires looking beyond the reproductive years into a phase where diminishing estrogen alters collagen elasticity, vascular supply, and tissue perfusion throughout the pelvis.
Estrogen is the primary driver of vaginal maturation. In its presence, the vaginal epithelium remains thick, rugated, and rich in glycogen. When systemic estrogen levels fall during menopause, the epithelial lining flattens, thins out, and loses its folds.
This cellular atrophy transforms the local ecosystem, predisposing women to chronic irritation, micro-abrasions, and secondary bacterial colonization.
Genitourinary Syndrome of Menopause is a comprehensive term encompassing a broad spectrum of symptoms associated with physical changes in the vulva, vagina, urethra, and bladder. Unlike transient acute infections, GSM is a chronic, progressive condition that rarely resolves spontaneously without targeted intervention. Affected women frequently report symptoms divided into distinct anatomical domains:
Midwives must proactively screen for these complaints during routine visits, as cultural stigma often prevents women from voluntarily reporting sexual or urinary discomfort.
The bladder trigone, urethra, and pelvic floor musculature share the same estrogen receptor density as the vagina. As systemic hormone levels drop, urethral mucosa thins and the closure pressure of the urethra declines. This physiological shift contributes to urinary frequency, urgency, and nocturia, mimicking chronic urinary tract infections even when urine cultures remain sterile. Furthermore, laxity in supporting connective tissues compromises urethral support, raising the risk of stress urinary incontinence during coughing, sneezing, or heavy lifting. Midwives need to differentiate between true bacterial cystitis and estrogen-depletion urethritis to avoid prescribing unnecessary antibiotics.
A thorough clinical evaluation begins with a detailed history exploring vulvovaginal symptoms, urinary habits, and sexual health. During the physical examination, the midwife inspects the external genitalia for signs of atrophy, such as loss of labial fat pad volume, pallor, fusion of the labia minora, or petechiae on the vaginal walls. The vaginal mucosa often appears pale, smooth, and shiny, with obliterated rugae and contact bleeding upon speculum insertion. Point-of-care vaginal pH testing or visual inspection helps confirm the diagnosis without requiring expensive laboratory panels. Midwives should also assess pelvic floor muscle tone using digital examination to grade strength and guide pelvic rehabilitation.
Managing urogenital aging requires individualized care that balances symptom severity, personal preference, and systemic health considerations. Non-hormonal vaginal moisturizers and lubricants provide immediate relief for dryness by restoring moisture and reducing friction during activity. For persistent or moderate-to-severe symptoms, low-dose local estrogen therapy remains the gold standard, delivering targeted relief directly to vaginal and urethral tissues with minimal systemic absorption. Midwives must counsel patients that local treatments take several weeks to show maximal effect and must be used consistently. In addition, incorporating pelvic floor muscle training helps improve structural support and mitigate urinary leakage.